ABSTRACT
UNLABELLED: We investigated bone turnover and its restoration in a large number of patients in the active phase and after cure of endogenous Cushing's syndrome. Furthermore, the usefulness of serum osteocalcin and collagen breakdown products as potential markers of active Cushing's syndrome was also evaluated. INTRODUCTION: Suppressed bone formation is one of the most characteristic features of Cushing's syndrome (CS). Despite numerous previous reports, many aspects of the disturbed bone metabolism of these patients are unexplored. In this study, we investigated the time course of bone marker changes after the cure of CS as well as correlations between bone markers and serum cortisol concentrations. METHODS: Eighty-seven patients with CS were studied. Patients were followed up to 48 months after surgical cure. Serum osteocalcin (OC) and collagen breakdown products (CTX) were measured with immunochemiluminescence method and compared to the results of 161 healthy controls. RESULTS: OC showed a negative, while CTX displayed a positive correlation with serum cortisol. Patients with diabetes mellitus and myopathy had significantly lower serum OC levels compared to those without these complications. The area under the curve of OC obtained by receiver-operating characteristics analysis for the discrimination of patients with CS from healthy controls was 0.9227. Postoperative OC increased rapidly from the first few days or weeks reaching its maximum at the sixth month and remained stable after the 24th postoperative month. CONCLUSIONS: Our study demonstrated significant correlations between serum cortisol and both bone formation and resorption markers in the active phase of CS. We propose that OC may serve as a sensitive biologic marker of glucocorticoid activity in endogenous CS during its active phase and it may reflect the clinical cure of the disease.
Subject(s)
Bone Remodeling/physiology , Cushing Syndrome/physiopathology , Adolescent , Adult , Aged , Biomarkers/blood , Body Mass Index , Collagen Type I/blood , Cushing Syndrome/blood , Cushing Syndrome/surgery , Female , Follow-Up Studies , Humans , Hydrocortisone/blood , Male , Middle Aged , Osteocalcin/blood , Peptides/blood , Postoperative Period , Treatment Outcome , Young AdultABSTRACT
UNLABELLED: We examined bone densitometric data in a four-year follow-up period before and after the cure of CS. Plasma cortisol concentrations were similar, but the duration of estimated glucocorticoid excess was longer in patients with prevalent bone fractures compared to those without fractures. After therapy of CS, bone area, BMC and BMD increased significantly at the LS and femur during follow-up, but they decreased at the forearm, suggesting redistribution of bone minerals from the peripheral to the axial skeleton. INTRODUCTION: Only a few studies report the changes in bone mineral density (BMD) after the cure of Cushing's syndrome (CS). METHODS: Forty-one patients with Cushing's disease, 21 patients with adrenal CS and 6 patients with ectopic CS were prospectively enrolled. BMD, bone mineral content (BMC) and bone area were measured by DXA. RESULTS: No significant correlations were found between serum cortisol concentrations and baseline bone densitometric data. After successful therapy of CS, bone area and BMD increased significantly at the lumbar spine (LS) and femur during follow-up, but they decreased at the forearm. The progressive increase in BMC at the LS had a significant negative correlation with the change of the BMC of radius in the first and second follow-up years. The change in the body mass index was an independent predictor for changes in BMC both at the LS and at the forearm at the second year of remission. CONCLUSIONS: The regional differences and the time-dependent changes of BMC suggest that the source of marked increase in axial BMC after the cure of CS is, at least partly, due to the redistribution of bone minerals from the peripheral to the axial skeleton.
Subject(s)
Bone Density/physiology , Bone and Bones/diagnostic imaging , Cushing Syndrome/physiopathology , Fractures, Bone/physiopathology , Absorptiometry, Photon , Adolescent , Adult , Aged , Cushing Syndrome/blood , Cushing Syndrome/surgery , Female , Fractures, Bone/epidemiology , Humans , Hydrocortisone/metabolism , Male , Middle Aged , Prospective Studies , Young AdultABSTRACT
BACKGROUND/AIMS: Glucocorticoids have an important role in the regulation of the immune system, and alterations in glucocorticoid signaling may have an impact on the pathophysiology of autoimmune and inflammatory disorders. Because polymorphisms of the glucocorticoid receptor (GR) gene, including the N363S, ER22/23EK, A3669G and BclI variants were found to influence glucocorticoid signalling, we examined whether these polymorphisms could be associated with the development or clinical manifestations of Graves ophthalmopathy (GO). METHODS: The carrier and allelic frequencies of the N363S, ER22/23EK, A3669G, and BclI polymorphisms of the GR were determined in 95 Hungarian outpatients with GO and 160 healthy controls. RESULTS: No significant changes were found in carrier frequencies of the four polymorphisms between GO patients and healthy controls. However, when GO patients were divided into two subgroups (American Thyroid Association Committee, ATA I-II vs ATA III or greater), the frequency of the polymorphic BclI allele was significantly higher in patients with ATA I-II compared with those with ATA III or more (p = 0.009). CONCLUSION: The significant association between the frequency of the polymorphic BclI allele and ATA stage distribution suggests that this polymorphism of the GR gene may affect clinical manifestations of GO, presumably due to an increased signaling of endogenous glucocorticoids.
Subject(s)
Graves Ophthalmopathy/genetics , Polymorphism, Genetic , Receptors, Glucocorticoid/genetics , Adult , Aged , Female , Gene Frequency , Graves Ophthalmopathy/pathology , Heterozygote , Humans , Male , Middle Aged , Severity of Illness IndexABSTRACT
The activity of prolyl endopeptidase (PEP), a cytosolic serine protease, was examined in developing primary cultures of the rat cerebral cortex between days 1 and 16, in vitro. Cells underwent remarkable differentiation during the first week in culture, as indicated by the formation of clusters and by the rapid development and fasciculation of neurites. The specific activity of PEP showed a rapid, about 5-fold increase by day 7. The morphology of cultures remained nearly unchanged and the activity of PEP slightly increased during the second week. Excitotoxic lesion of the neuronal component of mature cultures revealed that the majority (over 70%) of PEP activity is localised in glutamate-sensitive neurons. Our findings indicate that PEP may play some role during neuronal differentiation.